Clinical Trial Update: Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 single-blinded randomized controlled trial evaluating tissue expander/implant reconstruction in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED